Unlock Premium Data: Up to 50% Off InvestingProCLAIM SALE

GLOBAL MARKETS-Asian markets jump on vaccine, U.S. aid hopes; China data caps gains

Published 19/10/2020, 05:38 pm
© Reuters.
EUR/USD
-
UK100
-
XAU/USD
-
AXJO
-
JP225
-
PFE
-
DE30
-
DX
-
GC
-
LCO
-
UK100
-
ESU24
-
CL
-
EU50
-
MIAPJ0000PUS
-
CSI300
-

* Asian stock markets : https://tmsnrt.rs/2zpUAr4

* MSCI ex-Japan up 0.5%, Nikkei climbs 1.1%

* Pfizer could have coronavirus vaccine ready by end-2020

* Pelosi optimistic of U.S. fiscal aid before Nov elections

* Currencies tread water, oil slips, gold gains

By Swati Pandey

SYDNEY, Oct 19 (Reuters) - Asian markets advanced toward a recent 2-1/2-year peak on Monday powered by hopes of a U.S. fiscal package and expectations of a coronavirus vaccine by the end of this year, though gains were held back by weaker-than-expected Chinese economic data.

In early European trades, the pan-region Euro Stoxx 50 futures STXEc1 added 0.25%, German DAX futures FDXc1 were slightly higher while London's FTSE futures FFIc1 were down 0.07%.

MSCI's broadest index of Asia-Pacific shares outside Japan .MIAPJ0000PUS climbed 0.5% for its second straight day of gains, paring back slightly following third-quarter gross domestic product (GDP) data from China.

The index has risen in eight of the last 10 sessions amid a rally in risk assets buoyed by hopes of a coronavirus vaccine and expectations of a so-called "blue wave", which would see the Democrats claim victory in November's elections.

Chinese shares started higher but slipped into negative territory in afternoon trading after China's third-quarter GDP data rose 4.9%, missing expectations for a 5.2% growth. .CSI300 a positive sign, however, separate monthly indicators pointed to an expansion in economic activity.

Industrial output accelerated 6.9% in September from a year earlier, when analysts were looking for a 5.8% gain from a 5.6% rise in August.

Retail sales edged up 3.3% last month from a year earlier against expectations for 1.8% growth.

"The rebound in Q3 GDP was less strong than expected, but was still a decent 4.9% year on year. September data beat expectations, suggesting a pick-up in momentum towards the latter part of Q3," said Frances Cheung, head of macro strategy for Asia at Westpac in Singapore.

"The pick-up in momentum was broad based, which bodes well for the Q4 outlook."

Japan's Nikkei .N225 rose 1.1% while Australia's benchmark index .AXJO added 0.9%.

Boosting overall sentiment, drugmaker Pfizer Inc (NYSE:PFE) PFE.N said on Friday it could have a coronavirus vaccine ready in the United States by the end of this year. futures for the S&P 500 ESc1 jumped 0.7% in Asian trading after House Speaker Nancy Pelosi said on Sunday she was optimistic legislation on a wide-ranging coronavirus relief package could be pushed through before the election. with her negotiating partner, Treasury Secretary Steven Mnuchin, in the Middle East until Tuesday, such a timeframe would seem to be overly optimistic, analysts said.

Investors are also concerned about rising coronavirus cases. Global coronavirus cases rose by more than 400,000 for the first time late on Friday, a record one-day increase as much of Europe enacts new restrictions to curb the outbreak. in the week, key risk events include minutes of Australia's central bank meeting, the final U.S. presidential debate and global manufacturing indicators.

Action in currencies was muted with the U.S. dollar, usually perceived as a safe-haven asset, =USD flat at 93.696 against a basket of six major currencies. USD/

The euro EUR= was slightly weaker at $1.1708 and sterling hovered near two-week lows after UK Prime Minister Boris Johnson told businesses to get ready for a no-deal Brexit in case negotiations with the European Union fail to produce a free trade agreement. trade talks are flirting with collapse," ANZ economists said.

"UK Prime Minister Johnson said the UK needs to prepare for a no-deal outcome, as both sides cannot agree on a Canada-style FTA. Talks resume in London on Monday, but without the political willingness to shift ground, there is little the negotiators can achieve."

In commodities, Brent crude futures LCOc1 slipped 10 cents to $42.83 a barrel, and U.S. West Texas Intermediate (WTI) crude futures CLC1 fell 12 cents to $40.76 a barrel.

Spot gold XAU= rose 0.6% to $1,909.6 an ounce.

<^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^ Asia stock markets

https://tmsnrt.rs/2zpUAr4 Asia-Pacific valuations

https://tmsnrt.rs/2Dr2BQA

^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^> (Editing by Gerry Doyle and Jacqueline Wong)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.